Mclean joins public-private partnership to develop early interventions for schizophrenia

(McLean Hospital) Through the Accelerating Medicines Partnership (AMP), AMP Schizophrenia (SCZ) will work to discover promising biological markers that can help early detection of those at risk of developing schizophrenia.